Gestational age at birth, chronic conditions and school outcomes: a population-based data linkage study of children born in England
International Journal of Epidemiology · 2023
DOI: 10.1093/ije/dyac105 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Epidemiology, 2023. Verfasst von Nicolás Libuy und 5 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Health Informatics, University College London, London, UK. Hauptthemen laut MEDLINE: Infant, Premature, Premature Birth. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Department of Health, Wellcome Trust, Medical Research Council.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Introduction
We aimed to generate evidence about child development measured through school attainment and provision of special educational needs (SEN) across the spectrum of gestational age, including for children born early term and >41 weeks of gestation, with and without chronic health conditions.
Methods
We used a national linked dataset of hospital and education records of children born in England between 1 September 2004 and 31 August 2005. We evaluated school attainment at Key Stage 1 (KS1; age 7) and Key Stage 2 (KS2; age 11) and any SEN by age 11. We stratified analyses by chronic health conditions up to age 2, and size-for-gestation, and calculated population attributable fractions (PAF).
Results
Of 306 717 children, 5.8% were born <37 weeks gestation and 7.0% had a chronic condition. The percentage of children not achieving the expected level at KS1 increased from 7.6% at 41 weeks, to 50.0% at 24 weeks of gestation. A similar pattern was seen at KS2. SEN ranged from 29.0% at 41 weeks to 82.6% at 24 weeks. Children born early term (37–38 weeks of gestation) had poorer outcomes than those born at 40 weeks; 3.2% of children with SEN were attributable to having a chronic condition compared with 2.0% attributable to preterm birth.
Conclusions
Children born with early identified chronic conditions contribute more to the burden of poor school outcomes than preterm birth. Evaluation is needed of how early health characteristics can be used to improve preparation for education, before and at entry to school.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute of Health Informatics, University College London, London, UK.
- Centre for Longitudinal Studies, University College London, Social Research Institute, London, UK.
- Great Ormond Street Institute of Child Health, University College London, London, UK.
ORCID-Profile: Nicolás Libuy, Ruth Gilbert, Louise Mc Grath-Lone, Ruth Blackburn, David Etoori, Katie Harron
Förderung
- Department of Health
- Wellcome Trust
- Medical Research Council
- Economic and Social Research Council
- Administrative Data Research UK
- Administrative Data Research Centre for England
- National Institute for Health Research
- Great Ormond Street Hospital Biomedical Research Centre and Health Data Research UK
Zitieren
APA
Libuy, N., Gilbert, R., Mc Grath-Lone, L., Blackburn, R., Etoori, D., & Harron, K. (2023). Gestational age at birth, chronic conditions and school outcomes: a population-based data linkage study of children born in England. International Journal of Epidemiology. https://doi.org/10.1093/ije/dyac105
Vancouver
Libuy N, Gilbert R, Mc Grath-Lone L, Blackburn R, Etoori D, Harron K. Gestational age at birth, chronic conditions and school outcomes: a population-based data linkage study of children born in England. International Journal of Epidemiology. 2023. doi:10.1093/ije/dyac105
BibTeX
@article{Libuy2023,
author = {Libuy, Nicolás and Gilbert, Ruth and Mc Grath-Lone, Louise and Blackburn, Ruth and Etoori, David and Harron, Katie},
title = {Gestational age at birth, chronic conditions and school outcomes: a population-based data linkage study of children born in England},
journal = {International Journal of Epidemiology},
year = {2023},
doi = {10.1093/ije/dyac105}
}
EUVIMED